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 1.  Introduction 
 Tissue engineering and regenerative medicine (TERM) is a 
multidisciplinary fi eld of research that employs principles of 
chemistry, biology, and engineering sciences towards growth, 
development, and regeneration of damaged tissues or organs. [ 1 ] 
It involves scaffolds combined with cells and suitable biochem-
ical signals, which promote the design of new organs and tissues. 
 Among all tissues in the body, bone is the most widely 
investigated for tissue engineering due to its high potential for 
regeneration. Bone graft materials, as autografts and allografts, 
 Tissue engineering and regenerative medicine has been providing exciting 
technologies for the development of functional substitutes aimed to repair and 
regenerate damaged tissues and organs. Inspired by the hierarchical nature of 
bone, nanostructured biomaterials are gaining a singular attention for tissue 
engineering, owing their ability to promote cell adhesion and proliferation, and 
hence new bone growth, compared with conventional microsized materials. 
Of particular interest are nanocomposites involving biopolymeric matrices and 
bioactive nanosized fi llers. Biodegradability, high mechanical strength, and 
osteointegration and formation of ligamentous tissue are properties required 
for such materials. Biopolymers are advantageous due to their similarities with 
extracellular matrices, specifi c degradation rates, and good biological perfor-
mance. By its turn, calcium phosphates possess favorable osteoconductivity, 
resorbability, and biocompatibility. Herein, an overview on the available natural 
polymer/calcium phosphate nanocomposite materials, their design, and prop-
erties is presented. Scaffolds, hydrogels, and fi bers as biomimetic strategies for 
tissue engineering, and processing methodologies are described. The specifi c 
biological properties of the nanocomposites, as well as their interaction with 
cells, including the use of bioactive molecules, are highlighted. Nanocompos-
ites in vivo studies using animal models are also reviewed and discussed. 
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have been used to repair bone fractures 
and other defects, because of their oste-
oinductive and osteoconductive character-
istics. [ 2 ] Nevertheless, concern issues are 
associated with the risk of disease transfer, 
infection, chronic pain, possible immuno-
genicity, defi cient supply, and increase of 
operative time and cost. [ 3 ] 
 Despite their scarcity, biomaterials that 
are able to mimic the structural, mechan-
ical, and biological properties of natural 
tissues have been attracting a signifi cant 
attention. Meaningful progress has been 
made in designing and processing new 
materials in order to properly address 
cell activity. This is an important issue 
to be considered as regeneration pro-
cesses involve achieving the desired cell 
function, i.e., stimulate specifi c cellular 
responses and activate genes that stimu-
late cells differentiation and extracellular 
matrix (ECM) production for enhancing 
the regeneration of the damaged tissues. 
Inspired by the nature of bone, three-
dimensional, structurally hierarchical con-
structs and nanocomposites that can com-
prise several levels of organization, i.e., from the macroscopic 
tissue arrangement down to the molecular arrangement of pro-
teins have been required. [ 4 ] These nanostructured materials can 
provide enhanced mechanical performance and allow suitable 
transduction of the mechanical stimuli to the cellular level. [ 5 ] 
 Nanocomposites involving biodegradable and biopolymeric 
matrices and bioactive/resorbable nanofi llers have been con-
sidered as a strategy for tissue engineering and regeneration 
( Figure  1 ). The fi llers with nanosized features can intensely 
change the physical properties of the polymer matrix, allowing 
for the engineering of improved biomaterials that the individual 
materials cannot attain. The nanoparticles have a large surface 
area when compared to the conventional microsized fi llers, 
which can form a tight interface with the polymeric matrices, 
offering improved mechanical properties, while maintaining 
the favourable osteoconductivity and biocompatibility of the 
fi llers, thus infl uencing protein adsorption, cells adhesion, pro-
liferation and differentiation for new tissue formation. [ 6 ] 
 Biodegradable polymers from natural origin, like polysaccha-
rides (e.g., cellulose, chitin, glycosaminoglycans) and proteins 
(e.g., collagen, silk, fi brinogen, elastin) hold signifi cant simi-
larities with the ECM, chemical versatility, and good biological 
performance without toxicity or immunological reactions. [ 7–9 ] 
On the other hand, bioresorbable fi llers, such as calcium 
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biocompatibility. [ 10 ] 
 The present review provides a comprehensive overview 
of the most recent achievements relating to the design, pro-
cessing, and properties of resorbable nanocomposites for tissue 
engineering and regenerative medicine. 
 2.  Natural Polymers and Calcium Phosphate 
Material Properties 
 Different materials, such as natural/synthetic polymers, 
carbon nanotubes, hydroxyapatite (HAp), and silicates have 
been exploited for nanocomposite designing and processing, 
attending to diverse needs in TERM. Special interest has been 
given to the combination of biopolymers (i.e., proteins, poly-
saccharides, and glycosaminoglycans) and inorganic/ceramic 
fi llers as CaPs, which will provide biomaterial composites with 
optimized properties. Natural materials are usually the compo-
nents of the ECM, playing an important role in maintaining 
their structure. Besides, they have great design advantages and 
can easily promote cellular adhesion. On the other hand, CaPs 
are biocompatible, osteoconductive and biodegradable, but they 
have a limited range of mechanical strength that does not allow 
load-bearing applications. A brief description of the most prom-
ising material properties is herein presented. 
 2.1.  Biopolymers 
 2.1.1.  Proteins 
 2.1.1.1.  Collagen and Gelatin . Collagen and its denatured form, 
gelatin, are the most preferred ECM proteins used in tissue 
engineering due to the presence of several functional groups 
that can enhance osteoblast adhesion and migration. [ 9 ] Collagen 
and gelatin structures are presented in  Figure  2 . 
 Collagen is a fi brous protein, the major component of ECM 
and presents different morphologies in different tissues. It is, 
for example, found in bone (Type I), cartilage (Type II) and 
in blood vessel walls (Type III). This protein is non-cytotoxic, 
biocompatible, and biodegradable, but has low elasticity and 
mechanical strength, poor dimensional stability due to swelling 
in vivo, ability of being cross-linked to tailor the mechanical, 
degradation, and water-uptake properties, and the possibility of 
an antigenic response. [ 9 ] Collagen can be processed in fi lms, [ 7 ] 
fi bers, [ 8,10,12 ] and foams, [ 13–15 ] to engineer various tissues such 
as bone, cartilage, heart, ligament, and nerve. Collagen is also 
suitable to produce scaffolds for the culture of mesenchymal 
stem cells (MSCs) in tissue engineering. [ 16,17 ] 
 Considering the recognized biological properties of collagen, 
nanocomposites developed from this natural polymer and CaPs 
show increased mechanical strength as compared to pure col-
lagen. This behavior has been attributed to an increased rigidity 
of the nanocomposites with the addition of CaPs nanoparticles 
and to the strong interaction between calcium-binding resi-
dues on the polymer macromolecules and the surface of the 
nanoparticles. [ 18 ] Collagen/CaPs nanocomposites have been 
prepared using different processes, such as the direct addi-
tion of nano CaPs to the collagen solution, deposition of CaPs 
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nanoparticles into collagen, or by electrospinning a mixture of 
nanosized CaPs and collagen. [ 13,19 ] In a different approach, the 
group of Kikuchi prepared a porous HAp/collagen nanocom-
posite through a titration method for bone tissue engineering, 
as well as for bone fi ller. [ 20 ] Bone marrow cells co-cultured with 
MG63 osteoblast cells on the nanocomposites showed differen-
tiation to osteoclasts without differentiation supplements. 
 Gelatin is biocompatible, non-immunogenic and bioresorb-
able. [ 9 ] Despite gelatin lacks the structural characteristics of col-
lagen, it has higher solubility and lower cost when compared 
with collagen. Gelatin/CaPs nanocomposites with enhanced 
mechanical properties and good cell attachment have been 
developed. [ 21–23 ] The effects on gelatin-induced microstructures 
of HAp crystals were investigated by Ching-Chang Ko et al. [ 24 ] 
The results showed that increasing the content of gelatin, led to 
better plane strain modulus and fracture toughness. The gelatin 
appeared to shorten the HAp crystal distance, which consoli-
dated the internal structure of the composite and made the mate-
rial more rigid. Azami et al. [ 23 ] designed a gelatin/HAp nano-
structured scaffold with mechanical strength comparable to the 
spongy bone, as well as, an excellent capacity of cell attachment, 
migration and penetration into the pores of the nanocomposite. 
 2.1.1.2.  Silk Fibroin . Silks are a class of proteins produced from 
insects, spiders, and worms, which are composed of fi broin (70–
80%), the structural protein of silk fi bers, and sericin (20–30%), 
the water-soluble glue-like protein that encased fi broin. [ 26 ] Silk-
worm fi broin is of interest for biomedical engineering and it 
has to be extracted from the silkworm cocoon by elimination of 
the sericin via boiling in an alkaline solution. The degummed 
silkworm silk is then dissolved in lithium bromide, dialyzed 
and formed in an aqueous silk fi broin (SF) solution. A sche-
matic illustration of the SF solution preparation is shown in 
 Figure  3 . Bombyx mori SF has attracted increasing interest 
for bone, cartilage, and ligament tissue engineering due to its 
remarkable properties like elasticity, mechanical strength and 
toughness, biocompatibility, and biodegradability with control-
lable degradation rates. [ 27,28 ] The degradation rates of SF-based 
scaffolds can be adjusted by changing the crystallinity, molec-
ular weight, porosity, and β-sheet structure. SF is rich in β-sheet 
structures owing to hydrophobic domains which provide a good 
resistance to water solubility, and lead to the high mechan-
ical properties of these materials. [ 29 ] SF can be processed into 
fi bers, [ 27,30 ] membranes, [ 31 ] fi lms, [ 32 ] meshes, [ 33 ] foams, [ 34,35 ] and 
hydrogels [ 36 ] for the repair/regeneration of several tissues. 
 Silk-based composite scaffolds with enhanced physico-
chemical and biological properties have been developed for 
bone tissue engineering. [ 29,37,38 ] The incorporation of CaPs/silk 
powders into silk scaffolds showed an improved porous struc-
ture, osteogenic differentiation and in vivo bone formation. [ 38,39 ] 
Also, the incorporation of HAp in silk foams enhance the osteo-
conductivity and mechanical properties of the scaffolds. [ 35 ] 
 Silk scaffolds in combination with MSCs for bone and liga-
ment tissues engineering have been developed. [ 17,40 ] He et al. [ 40 ] 
demonstrated the fi brocartilaginous differentiation of bone 
marrow mesenchymal stem cells (BMSCs) in a co-culture 
system involving BMSCs, fi broblasts, and osteoblasts on a 
hybrid silk scaffold. The region of the osteoblasts-seeded scaf-
fold was coated with HAp to stimulate bone ingrowth. 
 2.1.2.  Polysaccharides 
 2.1.2.1.  Chitosan . Chitosan is a polysaccharide produced from 
marine crustacean shells, however, commercially available 
chitosan is produced from deacetylation of chitin ( Figure  4 ), 
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which is a natural polysaccharide found in crab, shrimp, lobster, 
coral, jellyfi sh, butterfl y, ladybug, mushroom and fungi. [ 42,43 ] 
Chitosan is a cationic polymer composed of randomly dis-
tributed N-acetyl glucosamine and D-glucosamine, varying in 
composition, sequence, and molecular chain length. Hence, 
chitosan enables the electrostatic interaction with negatively 
charged biomolecules and the interaction with cell membranes. 
Chitosan has been developed in diverse forms like fi lms, [ 44 ] 
fi bers, [ 45 ] foams, [ 14,46 ] hydrogel, [ 47 ] and particles, [ 48 ] for appli-
cations in bone and cartilage tissue engineering and wound 
healing, due to the excellent properties like biocompatibility, 
biodegradability, ability for cell ingrowth, and intrinsic antibac-
terial nature. [ 49 ] However, chitosan itself is not osteoconductive 
and it has low mechanical strength being unable to support 
load-bearing. The degradation rate of chitosan is inversely 
related to the degree of crystallinity and complete degradation 
can take months. 
 Hence, a diversity of materials, namely CaPs, has been 
combined with chitosan to produce stronger scaffolds 
with enhanced biological properties for bone tissue engi-
neering. [ 50–54 ] For example, physicochemical properties and in 
vitro cytotoxicity of chitosan/CaPs scaffolds were evaluated. [ 50 ] 
It was demonstrated that the scaffolds compressive strength 
is in the range of trabecular bone, and proliferation and dif-
ferentiation of MG63 cells on the scaffolds. Similarly, human 
MSCs cultured on chitosan/HAP composite scaffolds showed 
increased proliferation when compared to those cultured on 
pure chitosan. [ 52 ] Zhang et al. [ 54 ] prepared porous chitosan/
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 Figure 3.  Schematic of the silk fi broin process and its chemical structure. Adapted with permission. [ 41 ] Copyright 2008, Nature Publishing Group.
 Figure 2.  Schematic representation of the process of denaturation of collagen and obtention of gelatin. Adapted with permission. [ 25 ] Copyright 1991, 
SoundViewPress/Artprice.
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HAp scaffolds with 3D oriented structure showing a high 
degree of proliferation of MC3T3-E1 cell line, adhesion and 
alkaline phosphate activity. 
 2.1.2.2.  Alginate . Alginate is a natural polymer that can be 
obtained from brown algae. It is composed of two monomers, 
(1,4)-linked β-D-mannuronate (M) and α-L-guluronate (G) 
( Figure  5 ). Alginates extracted from different sources have dif-
ferent M and G contents along with the length of each block, 
infl uencing the properties of the alginate. [ 55 ] For example, 
increasing the length of G block and molecular weight, the 
mechanical properties of the alginate will be improved. [ 56 ] Also, 
high M content are immunogenic and more potent in inducing 
cytokine production as compared to G content. [ 57 ] 
 Alginate is increasingly investigated for tissue engineering, 
wound healing and drug delivery, due to its biocompatibility, 
low toxicity and immunogenicity, and controllable gela-
tion. [ 55,58 ] It is normally used in the form of a hydrogel, [ 59 ] but 
it can also be used as gels, [ 60 ] and fi bers [ 61 ] for cell immobi-
lization and proliferation, as well as injectable pastes. [ 62,63 ] 
Alginate has been combined with inorganic materials to engi-
neer and repair/regeneration bone tissue. Alginate, gelatin, 
and biphasic CaPs were fabricated by the Schiff-base reaction 
and demonstrate adjustable gelation and biodegradation 
time, good mechanical strength, and excellent biocompat-
ibility. [ 64 ] Calcium phosphate cement and alginate scaffolds 
were prepared for the culture and expansion of osteoblastic 
cells showing an active proliferative potential and osteogenic 
differentiation. [ 63,65 ] In addition, human umbilical cord MSCs-
encapsulating calcium phosphate cement/alginate composite 
paste have demonstrated mechanical strength matched the 
reported values of cancellous bone, and the encapsulated 
cells remained viable and osteo differentiated, yielding high 
alkaline phosphatase (ALP), osteocalcin, collagen Type I, and 
osterix gene expressions. [ 66 ] Likewise, it was reported that 
a hybrid scaffold of HAp and alginate hydrogel promote the 
formation of chondrocyte of a calcifi ed cartilage-like matrix in 
vitro for the regeneration of the osteochondral interface tissue 
engineering. [ 67 ] 
 2.1.2.3.  Gellan Gum and Derivatives . Gellan gum (GG) is an 
anionic, high molecular weight, extracellular polysaccharide 
produced by the fermentation of the organism  Sphingomonas 
elodea bacterium (originally designated  Pseudomonas elodea ), 
which lives on the algae  Elodea Canadensis . GG consists of 
approximately, 60% glucose, 20% glucuronic acid, and 20% 
rhamnose as a repeating unit, and two acyl groups, acetate 
and glycerate bound to glucose residue adjacent to glucuronic 
( Figure  6 ). [ 68,69 ] It has a high gel strength, excellent stability, 
and thermally reversible gel, which is formed in the presence 
of metallic ions. [ 70 ] 
 GG is available as native form or deacetylated form by 
removing the acetyl groups, resulting in harder and more 
brittle gels with higher thermal stability. [ 71 ] Also, it is available 
in a clarifi ed form, by fi ltration of hot deacetylated GG, for 
microbiological media, plant tissue culture, and pharmaceutical 
application purposes. [ 68,72 ] 
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 Methacrylated GG is a derivative form of GG produced 
through chemical modifi cation by means of methacrylation of 
low acyl GG. 
 It has been reported GG to be used in several acellular and 
cellular tissue engineering strategies. [ 73,74 ] For example, GG-
based hydrogels can be tunable for the regeneration of interver-
tebral disc to improve their mechanical properties, to control 
endothelial cells infi ltration and blood vessel ingrowth’s. [ 73 ] 
In addition, GG-based hydrogels blended with HAp particles 
have been proposed for bone and osteochondral applications 
showing greater mechanical and biological properties in com-
parison to the polymeric hydrogel. [ 75 ] Bilayered GG/GG-HAp 
hydrogels were produced for osteochondral tissue engineering 
applications, by joining both solutions of GG 2% (w/v) with 
and without HAp (20 wt.%) for bony and cartilage parts, respec-
tively. [ 76 ] Results showed that the bilayered scaffolds possessed 
83.4 ± 0.8% porosity, 279.3 ± 38.6 µm pore size and intercon-
nectivity of 62.2 ± 5.4%. 
 2.1.3.  Glycosaminoglycans 
 2.1.3.1.  Hyaluronic Acid . Hyaluronic acid (HA) is an ani-
onic, non-sulfated glycosaminoglycan consisting of repeating 
D-glucuronic acid-β-1,3-N-acetyl-D-glucosamine-β-1,4 units 
( Figure  7 ). [ 77,78 ] It is one of the major constituent of the 
ECM present in all connective tissues, presenting good vis-
coelasticity and water-binding ability, biocompatibility and 
non-immunogenicity, which make it suitable to be used in sev-
eral biomedical applications for tissue engineering and regen-
erative medicine, as well as for cell encapsulation [ 79 ] and as a 
drug delivery system. [ 78,80 ] HA can be chemically modifi ed in 
order to alter the physico-chemical and biological properties of 
the resulting materials, and their derivatives and cross-linked 
materials have been created in different forms such as hydro-
gels, [ 81 ] fi bers, [ 82,83 ] meshes, [ 83,84 ] and foams. [ 85 ] 
 HA-based composites aiming to improve structural integ-
rity, fracture strength, and toughness of scaffolds have been 
reported for tissue engineering applications. [ 86 ] In addition, the 
incorporation of HA in cross-linked networks have shown high 
potential for the treatment of cartilage damage. [ 63 ] 
 2.2.  Calcium Phosphate-Based Materials 
 2.2.1.  Calcium Phosphates 
 CaPs are the chemical compounds of special interest for 
human beings due to their similarity with the inorganic part 
of major normal (bones, teeth and antlers) calcifi ed tissues of 
mammals. [ 87,88 ] CaPs possess remarkable biocompatibility, oste-
oconductivity, bioresorbability, and direct bonding to bone. [ 88–90 ] 
The most relevant CaPs are presented in  Table  1 . 
 CaPs commonly used for tissue engineering are β-TCP 
and HAp. β-TCP is a high temperature phase of CaPs, which 
only can be obtained by its thermal decomposition at tempera-
tures above 800 °C. HAp is highly crystalline and is the most 
stable and least soluble CaPs in an aqueous solution below pH 
4.2. [ 90 ] HAp can be prepared using wet methods, such as pre-
cipitation, [ 99 ] hydrothermal [ 100 ] and hydrolysis of other CaPs. 
HAp can be also obtained from a solid-state reaction of, for 
example, MCPM, DCPA, DCPD, OCP, with calcium oxide, 
calcium hydroxide or calcium carbonate, above 1200 °C. The 
detailed information on HAp synthesis is reported and avail-
able elsewhere. [ 101 ] 
 Although β-TCP and HAp have similarities in their chemical 
composition, they differ in their biological resorbing capability. 
The resorption of a ceramic HAp is slow, and once implanted 
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into the body, HAp may remain integrated into the regenerated 
bone tissue, while β-TCP is completely reabsorbed. [ 102 ] Clinical 
applications of pure HAp can be improved with the bioresorb-
able β-TCP for better bone regeneration. The main attractive 
feature of these materials is their ability to form a strong direct 
bond with the host tissue resulting in a strong interface. [ 101 ] 
However, these materials are limited to non-load-bearing 
applications due to their poor mechanical properties. Hence, 
research efforts are focused on combining these materials with 
polymers as composite materials. [ 21,103,104 ] 
 2.2.2.  Ionic Co-Substitutions in Calcium Phosphates 
 The mineral component of bone is similar to HAp but contains 
other ions in composition, as illustrated in  Table  2 . 
 Each of the aforementioned elements is considered to play 
a pivotal role for the behavior of biological apatites leading to 
better produced biomaterials. [ 105 ] Therefore, the ionic incorpo-
ration into the structure of synthetic CaPs phases, namely in 
β-TCP ( Figure  8 a) and HAp (Figure  8 b), can affect the lattice 
structure, microstructure, crystallinity, and dissolution rate 
of CaPs. [ 106,107 ] Magnesium has its own signifi cance in the 
calcifi cation process and on bone fragility, and has indirect 
infl uence on the mineral metabolism; [ 108 ] strontium is con-
sidered as a bone-seeking element that presents a benefi cial 
effect on the bone growth, and has the ability to decrease 
bone resorption and to enhance bone formation; [ 109 ] zinc is 
able to promote osteoblast cell proliferation and differentia-
tion; [ 110 ] potassium has a versatile nature in the regulation of 
biochemical process and also an important role in the apatite 
mineral nucleation process; [ 111 ] sodium has a potential role in 
cell adhesion and in the bone metabolism and resorption pro-
cesses; [ 112 ] chlorine has the ability to develop an acidic envi-
ronment on the surface of bone that activates osteoclasts in 
the bone resorption process. [ 113 ] In addition, the incorporation 
of carbonate or fl uoride into a DNA–fi bronectin–apatite com-
posite layer for tissue engineering aiming to adjust the layer 
solubility was developed by Yazaki and their co-authors. [ 114 ] 
The incorporation of carbonate increased the effi ciency of 
gene transfer on the layer, while fl uoride decreased the effi -
ciency and delayed the timing of gene transfer dose-depend-
ently. Also, manganese (Mn), detected as minor constituents 
of teeth and bone, regulates bone remodeling because its 
low content in the body is associated with the increase of 
the extracellular concentration of calcium, phosphates and 
phosphatase. [ 115 ] 
 Synthesis, structural and mechanical studies, and in vitro 
analysis of CaPs with ionic incorporation have been reported, 
namely Mg, [ 118 ] Sr, [ 119,120 ] Zn, [ 107,120 ] Na, [ 121 ] F, [ 122 ] , Ag, [ 123,124 ] 
Mn, [ 125 ] Si, [ 120,126 ] and Ba. [ 127 ] Kose et al. [ 123 ] showed that silver 
ion-containing CaP-based ceramic nanopowder-coated implants 
led to an increase in resistance to bacterial colonization com-
pared to HAp-coated, and uncoated titanium implants. Torres 
et al. [ 125 ] prepared Mn-doped β-TCP powders and reported that 
Mn-doping signifi cantly affected the structure and morphology 
of β-TCP powders. In vitro proliferation and differentiation 
assays of MC3T3-E1 osteoblastic-like cells, grown in the pres-
ence of the powders, revealed that the biological benefi ts of 
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 Table 1.  Relevant calcium phosphates. 
Calcium phosphates Formula Ca/P Properties References
Monocalcium phosphate monohydrate (MCPM) Ca(H 2 PO 4 ) 2 .H 2 O 0.5 Not biocompatible  [90,91] 
Monocalcium phosphate anhydrous (MCPA) Ca(H 2 PO 4 ) 2 0.5  [90,91] 
Dicalcium phosphate dihydrate (DCPD or brushite) Ca(HPO 4 ).2H 2 O 1.0 Biocompatible, biodegradable and 
osteoconductive
 [92] 
Dicalcium phosphate anhydrous (DCPA) Ca(HPO 4 ) 1.0  [90,91] 
Octacalcium phosphate (OCP) Ca 8 (HPO 4 ) 2 (PO 4 ) 4 .5H 2 O 1.33 Metastable precursor of CaPs that 
transforms into HAp
 [93] 
Amorphous calcium phosphate (ACP) Ca x H y (PO 4 ) z .nH 2 O n = 3 – 4.5 1.2 – 2.2 Lacks long range order  [94] 
Calcium defi cient hydroxyapatite (CDHA) Ca 9 (HPO 4 )(PO 4 ) 5 (OH) 1.5 – 1.67 Poorly crystalline  [91] 
α-Tricalcium phosphate (α-TCP) α -Ca 3 (PO 4 ) 2 1.5 Degradable  [95] 
β-Tricalcium phosphate (β-TCP) β -Ca 3 (PO 4 ) 2 1.5  [96,97] 
Hydroxyapatite (HAp) Ca 10 (PO 4 ) 6 (OH) 2 1.67 Osteoconductive  [97] 
Tetracalcium phosphate (TTCP) Ca 4 (PO 4 ) 2 O 2.0 Biocompatible but poorly biodegradable  [98] 
 Table 2.  Composition of inorganic phases of adult human calcifi ed 
tissues. 
Composition (wt%) Bone Enamel Dentin
Calcium (Ca) 34.8 36.5 35.1
Phosphorus (P) 15.2 17.7 16.9
Sodium (Na) 0.9 0.50 0.60
Magnesium (Mg) 0.72 0.44 1.23
Potassium (K) 0.03 0.08 0.05
Zinc (Zn) 0.0126 – 0.0217 − −
Fluoride (F) 0.03 0.01 0.06
Chloride (Cl) 0.13 0.30 0.01
Carbonates 7.4 3.5 5.6
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Mn-doped β-TCP are limited to lower Mn incorporation levels 
and potentially related to their surface microstructure. Another 
interesting work prepared Si-substituted nano-CaPs followed 
by the fabrication of multilayered scaffolds. [ 126 ] In that study, 
it was reported that the silicon content facilitates a progressive 
change of nano-HAp structure to nano-TCP, and enhanced 
adhesion, spreading, growth and proliferation of osteoblasts on 
the scaffolds, which might be considered for bone tissue engi-
neering, with potential applications in bone reconstruction and 
regeneration. 
 2.2.3.  Calcium Phosphate Cements 
 Calcium phosphate-based cements (CPC) as injectable pastes 
with options for cell delivery in tissue engineering of bone 
are also a strong subject of research. [ 128,129 ] CPC are made 
of an aqueous solution and CaPs, which upon mixing, dis-
solve and precipitate into a less soluble CaP and set by the 
entanglement of the growth crystals, providing a mechanical 
rigidity to the cement. [ 130 ] When the paste becomes suffi -
ciently stiff, it can be injected into a defect as a substitute for 
the damaged part of bone, where it hardens in situ within 
the operating theatre. The handling characteristics and the 
ability to harden at body temperature make it an attractive 
delivery vehicle for therapeutic agents in orthopaedic applica-
tions. For example, modifi ed CPC with alginate gel showed 
good cell proliferation, and increased osteogenic analysis 
associated with hMSCs, suggesting that this material can be 
used as a cell delivery vehicle for bone regeneration. [ 128 ] In 
addition, CPC loaded with recombinant human bone mor-
phogenetic protein (rh-BMP-2) revealed signifi cantly accel-
erated healing in bone defects. [ 131 ] Czechowska et al. [ 132 ] 
prepared a cement-type implant material composed of α-TCP 
and chitosan with the chemical stability and high bioactive 
potential demonstrated through in vitro studies in simulated 
body fl uid. 
 3.  Biomimetic Nanocomposites Based 
on Biopolymers and Calcium Phosphates 
 Biomimetic strategies to develop nanocomposites for TERM 
rely on bioactive structures with controlled geometry able to 
replicate the natural ECM found in vivo and their ability to 
direct cell-matrix and cell–cell interactions. 
 Nanocomposites consist of a polymer matrix combined with 
nanosized CaPs, which allows tailoring the desired degrada-
tion and resorption kinetics of the matrix. Furthermore, nano-
sized CaPs are able to improve the tissue bonding behavior of 
the polymeric materials, as well as, cell adhesion and differ-
entiation. Among the biomimetic nanocomposites that have 
been developed to engineer different tissues, three-dimensional 
(3D) porous scaffolds, hydrogels, and nanofi brous scaffolds 
with controlled geometry and structures are the ones selected 
for discussion due to its important role in tissue engineering 
scaffolding. Each type of material offers its own advantages and 
disadvantages in mimicking the organization of native tissue 
structure. A description of each design is issued as follows. 
 3.1.  Nanocomposite Porous Scaffolds 
 Scaffolds are designed to act as a 3D support structure to the 
surrounding bone tissue mimicking ECM, with advantageous 
characteristics, including: (i) porous structure that promotes 
cell-biomaterial interactions, cell adhesion, growth and migra-
tion, (ii) interconnected pores to facilitate transport of mass, 
nutrients, and regulatory factors to allow cell survival, prolifera-
tion, and differentiation, (iii) adequate mechanical properties 
as tensile strength and elasticity, (iv) controlled degradation, 
(v) synthesis of new bone formation with homogeneous distri-
bution to avoid necrosis, and (vi) minimal degree of infl amma-
tion or toxicity in vivo. [ 133 ] Furthermore, scaffolds have desirable 
characteristics for cell transfer into a defect site and to restrict 
cell loss, instead of simple injection of cells to the defects. [ 134 ] 
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 Figure 8.  Schematic representation of crystal structure of a) β-TCP after Yashima et al. [ 116 ] and b) HAp after Wilson et al., [ 117 ] projected down the 
crystallographic  b -axis.
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 Composite scaffolds commercially available are manufac-
tured from collagen and CaPs consisting of HAp, β-TCP, and 
biphasic CaP that combine both structures to tune the degra-
dability. [ 135 ] Collagen is the most abundant polymer in bone 
tissue, thus is one of the most obvious candidates for combina-
tion with nanosized CaPs. 
 Nanocomposite scaffolds have been fabricated with specifi c 
pore size, porosity, surface-area-to-volume ratio and crystal-
linity, by means of different technologies including foam rep-
lica method, [ 136 ] solvent casting and particulate-leaching, [ 137 ] 
freeze-drying, [ 138 ] phase separation, [ 139 ] gas foaming, [ 140 ] rapid 
prototyping, [ 141 ] and electrospinning. [ 142 ] 
 The challenge is the production of scaffolds ensuring a good 
compatibility between the phases while keeping the porous 
structure and the mechanical properties. Also, it is important to 
achieve a homogeneous distribution of nanosized CaP particles 
inside the polymer. Methods used to maximize the CaP nano-
particles distribution include precipitation in situ of the mineral 
crystals in the polymer matrix or by the use of dispersants as 
sodium citrate. [ 103,143,144 ] For example, nanocomposite scaffolds 
made of SF and CaPs by using an in situ synthesis method, 
where phosphate ions are added into the calcium chloride solu-
tion with dissolved SF, followed by the addition of ammonia 
dibasic phosphate solution by means of salt-leaching/freeze-
drying techniques. [ 103,144 ]  Figure  9 presents scanning electron 
microscopy (SEM) images of the scaffolds showing a macro/
micro porous structure. The scaffolds presented highly intercon-
nected macro-pores with sizes around 500 µm, and micro-pores 
with a size range of 10–100 µm, as shown in Figure  9 (a,b,c). 
It is also shown the formation of caulifl ower-like apatite clus-
ters with a size of 700 nm, on the surface of the scaffold (Figure 
 9 d). The size of the CaP particles in the composite scaffolds was 
less than 200 nm confi rmed through energy dispersive X-ray 
detector spectra (Figure  9 f). 
 Kim et al. [ 145 ] prepared aqueous-derived SF scaffolds with the 
addition of polyaspartic acid, followed by the controlled depo-
sition of CaPs by exposure to chloride and sodium phosphate 
monobasic solutions. It was observed that the carboxyl groups 
from the polyaspartic acid enhanced apatite deposition on the 
SF substrates. In another study, HAp was synthesized in SF by 
the addition of phosphate ions into the calcium chloride/eth-
anol/water solution with dissolved SF. [ 146 ] On the other hand, 
Bhumiratana and his colleagues embedded HAp micro-parti-
cles in silk foams to generate highly osteogenic composite scaf-
folds capable of inducing the formation of tissue-engineered 
bone. [ 35 ] Chen et al. [ 147 ] developed collagen-SF/HAp nanocom-
posites via an in situ precipitation technique. Morphology 
studies showed that HAp particles were distributed uniformly 
in the polymer matrix and possess a size ranging from 30 to 
100 nm, which were composed of more fi ne sub-particles with 
sizes ranging from of 2–5 nm without regular crystallographic 
orientation. All these strategies allowed the formation of nano-
sized CaP particles inside the polymeric matrix. 
 The design, characterization, and biological evaluation of 
various natural polymer/CaP nanocomposite scaffolds with 
the potential for tissue engineering and regenerative medicine 
have been reported. [ 21,23,103,136,141,144,147–153 ] Cunniffe’s group 
developed a collagen/nano-HAp composite scaffold with higher 
mechanical properties and the same high biological activity 
compared with the collagen control scaffold (5.50 ± 1.70 vs 
0.30 ± 0.09 kPa). [ 150 ] Yan et al. [ 103 ] prepared a composite scaf-
fold made from SF and nanosized CaP with self-mineralization 
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 Figure 9.  Scanning electron micrographs of SF/nano-CaP scaffolds: a-c) microstructure, d,e) distribution and particle size of the CaP particles in the 
scaffolds, and f) energy dispersive X-ray detector spectra of (e). Adapted with permission. [ 103 ] Copyright 2013, Future Medicine.
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[ 21 ] produced gelatin/
HAp nanocomposite scaffolds, using a freeze-drying technique, 
with elastic modulus similar to natural bone. Biological tests 
showed good adhesion and proliferation of human MSCs. In 
another study, a bio-hybrid SF/CaP/poly lactic-co-glycolic acid 
(PLGA) nanocomposite scaffold was produced using freeze-
drying and electrospinning to be used as a delivery system. [ 151 ] 
It was shown that these nanocomposites provide an optimal 
microenvironment in terms of porosity, physical and chem-
ical structure. The SF/CaP microstructure has shown highly 
porous structure suitable for the transportation of nutrients 
and oxygen. In addition, PLGA was successfully electrospun on 
the surface of VEGF loaded SF/CaP nanocomposite and formed 
highly uniform nanofi bers with a diameter of 300–500 nm. The 
porosity of freeze-dried substrates was in the range of 70–75%, 
which considered enhancing the exchange of nutrients and 
waste materials. Eftekhari et al. [ 152 ] developed a novel porous 
nanocomposite composed of cotton-sourced cellulose micro-
crystals, HAp nanoparticles and poly l-lactide acid with a pre-
treatment of particles by using sodium dodecyl sulfate (SDS) 
as a coupling agent. The results indicated that the incorpora-
tion of cellulose and HAp nanoparticles improves the mechan-
ical strength of the nanocomposites to be used for bone tissue 
regeneration. Another work was reported collagen/nano-HAp 
biocomposite scaffolds development for bone regeneration, 
by applying cryogelation method as an alternative for freeze-
drying. [ 153 ] The composites showed improved mechanical prop-
erties and high cellular proliferation. 
 3.2.  Nanocomposite Hydrogels 
 Hydrogels consist of a 3D network that is highly hydrated, 
but mechanically fragile due to their randomly arranged 
chemically cross-linked network. [ 154 ] Hydrogel materials 
hold structural and compositional similarities with the ECM 
making them attractive scaffolds owing to their swollen net-
work structure, biocompatibility, effi cient mass transfer, and 
ability to encapsulate cells and biomolecules. [ 154 ] These prop-
erties are infl uenced by the nature of the polymer chains 
and degree of cross-linking, molecular arrangement, and the 
amount of water they absorb. [ 155 ] Hydrogels usually exhibit 
a hydrophilic network porous structure with interconnected 
pores (>10 µm) to allow cell infi ltration and deployment, and 
provide an increased surface area for cell attachment and 
interaction. Moreover, hydrogel porosity may be controlled 
by solvent casting/particulate leaching, phase separation, gas 
foaming, solvent evaporation, freeze-drying, and blending 
with non-cross-linkable linear polymers. [ 156 ] Hydrogel net-
works can be engineered, into different sizes and shapes, as 
thin fi lms, sheets, spheres, rods, hollow tubes, and bellows, 
due to their unique physical properties. [ 157 ] From the tissue 
engineering point of view, hydrogels can be used as 3D struc-
tures that organize cells and present stimuli to direct the 
formation of a desired tissue, as space fi lling agents, and as 
delivery vehicles for bioactive molecules. [ 158 ] Excellent reviews 
regarding a depth description of hydrogel properties are well 
published. [ 154,159 ] 
 Nanocomposite hydrogels are defi ned as an organic-inor-
ganic network structure, chemically or physically cross-linked 
with nanoparticles. [ 160 ] Compared to the conventional ones, 
nanocomposite hydrogels have enhanced chemical, physical, 
electrical and biological properties, mainly attributed to the 
improved interactions between the polymeric network and the 
nanoparticles. Nevertheless, hydrogel nanocomposites lack of 
some essential features, as biodegradation and stimuli respon-
siveness, which can be enhanced by combining multiple phases 
within a nanocomposite hydrogel. [ 161 ] 
 Hydrogels produced from inorganic nanoparticles, as 
nanosized CaPs, incorporating a natural or synthetic poly-
meric hydrogel matrix can provide not only greater mechan-
ical strength, but also tuning the bioactive characteristics to 
the network. For example, an injectable and thermo-sensitive 
poly(ethylene glycol) (PEG) – poly(ε-caprolactone) (PCL) – PEG 
copolymer/collagen/nano-HAp hydrogel composite for guided 
bone regeneration was developed and investigated in vivo bio-
compatibility and biodegradability by implanting the hydrogel 
composite in rats by Fu et al. [ 162 ] The results showed good bio-
compatibility, biodegradability, and new bone tissue formation 
of the nanocomposite. In another study, nanosized HAp was 
incorporated into a PEG matrix aiming the production of highly 
tough and elastomeric nanocomposite hydrogels. [ 163 ] The mor-
phologies of the nanocomposite hydrogel fractured surfaces 
show highly porous structures and interconnected porous 
structures with pore sizes between 100−300 nm ( Figure  10 ). 
The incorporation of HAp nanoparticles enhanced the mechan-
ical properties of the nanocomposite networks, due to the nano-
particle interactions that interfere with the cross-linking of PEG 
during the photopolymerization. Additionally, the presence 
of nano-HAp provided osteoblast cell adhesion and bioactive 
attachment sites to the osteoblast cells, when compared with 
PEG hydrogels. 
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 Figure 10.  Microstructure of the nanocomposite hydrogel with 5% of nanosized HAp concentration. Arrow indicates the polymer-nanoparticle aggre-
gates. Scale bar 2 µm. Adapted with permission. [ 163 ] Copyright 2011, American Chemical Society.
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 To date, scarce reports on nanocomposite hydrogels pro-
duced from natural polymers and nanosized CaP can be 
found. [ 162,164,165 ]  Nejadnik et al. [ 164 ] developed an injectable, 
cohesive nanocomposite hydrogel based on CaP nanoparticles 
and bisphosphonate-functionalized HA. The results showed 
that the nanocomposites display a capacity for self-healing 
and adhesiveness to mineral surfaces, such as enamel and 
HAp. Moreover, the nanocomposites are biodegradable upon 
in vitro and in vivo testing and show bone interactive capacity 
evidenced by bone ingrowth into material remnants. Another 
work describes the creation of nanocomposites hydrogel made 
of xanthan cross-linked with citric acid and HAp hydrogel, by 
using xanthan modifi ed nano-HAp and its equivalent Sr sub-
stituted. [ 165 ] The enrichment of HAp nanoparticles by xanthan 
enhanced the colloidal stability and compatibility between 
the chains and the nanoparticles. Nanocomposites presented 
improved mechanical properties in comparison to bare xan-
than networks or to nanocomposites with HAp. Also, the ALP 
activity increased in both nanocomposites, being more pro-
nounced for the samples substituted with Sr. 
 3.3.  Nanocomposite Fibrous Scaffolds 
 Fibrous scaffolds are a good option to mimic the fi brous struc-
ture of the native ECM, with advantageous morphologies to 
porous scaffolds and hydrogels. [ 166 ] Nanofi bers display a simi-
larity to the network of collagen fi brils each about 50–500 nm 
diameter. They possess high porosities (up to 95%), isotropic 
structures, and homogeneous fi ber size and pore distribution. 
In addition, this type of scaffold is able for cell adhesion and 
proliferation, since cells adhere and organize well around fi bers 
with dimensions smaller than the diameter of the cells. [ 167 ] The 
mechanical properties of fi brous scaffolds are dependent on 
their composition, fi ber diameter and orientation. [ 168 ] Further-
more, nanoscale fi brous scaffolds with well-controlled patterned 
structures have received particular interest to enhance cell 
functions as cell adhesion, migration, proliferation and dif-
ferentiation. [ 169 ] A nanofi ber scaffold has been used in tissue 
engineering for bone, cartilage, ligament, skeletal muscle, skin, 
neural tissue engineering, and as vehicle for the controlled 
delivery of drugs, proteins, and DNA. [ 170 ] 
 Nanocomposite fi brous scaffolds can be obtained from a 
polymer and a nanosized ceramic phase, by using molecular 
self-assembly, phase separation, and electrospinning fabrica-
tion techniques. Molecular self-assembly is able to produce 
highly ordered nanofi bers but it is limited to molecules for 
self-assembly. A phase separation method can only produce 
randomly distributed fi bers in the sub-micrometer range and 
allows for the control of pore architectures. Electrospinning 
can generate fi bers, from nano- to micro-size, with controllable 
pore size, fi ber size and stiffness, and matrix turnover, being 
the most widely studied technique. [ 171 ] Also, the incorporation 
of bioactive agents to electrospun fi bers can lead to enhanced 
biomimetic scaffolds, since cell-substrate interaction is strongly 
affected by the presence of chemical cues, able to support cell 
adhesion, proliferation and differentiation. [ 172 ] 
 Electrospun nanofi ber-based natural polymer and CaP 
composites are being explored as scaffolds similar to natural 
ECM for TERM applications. [ 53,142,173–176 ] Chae et al. [ 142 ] suc-
cessfully fabricated HAp/alginate nanocomposite fi brous scaf-
folds via electrospinning and a novel in situ synthesis of HAp 
that mimics mineralized collagen fi brils in bone tissue. They 
hypothesized that the in situ nucleation and crystal growth 
of HAp on electrospun nanofi bers during the cross-linking 
treatment would induce homogeneous deposition of the HAp 
nanocrystals on the nanofi bers and overcome the drawbacks 
of the mechanically blended/electrospun composite nano-
fi bers. Results showed that the electrospun HAp/alginate scaf-
fold composed of random nanofi bers containing homogene-
ously distributed HAp nanocrystals presented in  Figure  11 . 
The in vitro cell study showed good adhesion of rat calvarial 
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 Figure 11.  Microscopy images of a) electrospun HAp/alginate and b) cross-linked/in situ synthesized HAp/alginate scaffolds. c) Illustration of the 
cross-linked/in situ synthesized HAp/alginate scaffold. Adapted with permission. [ 142 ] Copyright 2013, Springer.
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osteoblasts to the scaffolds, being more stable attached on 
HAp/alginate scaffolds than attachment on pure alginate, 
presenting a stretched and elongated shape into a spindle-
shape on the HAp/alginate scaffolds. Liu et al. [ 173 ] developed 
a nanofi brous gelatin/apatite composite scaffold using ther-
mally induced phase separation technique for bone tissue 
engineering. The scaffolds showed high porosity and inter-
connectivity. Also, the composite scaffolds demonstrated high 
mechanical strength and favorable osteoblastic cell differentia-
tion due to the addition of apatite. Kim et al. [ 175 ] produced elec-
trospun SF composite scaffolds by uniformly dispersing HAp 
nanoparticles within SF nanofi bers. The composite scaffolds 
showed increased mechanical properties with the increase of 
HAp content up to 20 wt% and good biocompatibility. 
 A different approach was used to fabricate SF nanofi bers 
containing HAp nanoparticles with desirable properties. [ 176 ] 
This technique employing a three-way stopcock connector was 
used to electrospun a blend solution of SF and HAp together 
in aqueous solution. In  Figure  12 , SF nanofi bers and SF nano-
fi bers modifi ed with HAp nanoparticles are demonstrated. 
The authors concluded that HAp nanoparticles enhanced the 
β-sheet conformation of SF improving their properties. Also, 
the nanofi bers showed non-toxic behavior and good attachment 
of fi broblast cells after incubation. 
 HAp nanoparticles have also been used in combination 
with chitosan to produce genipin-crosslinked nanofi brous scaf-
folds. [ 177 ] These nanofi brous composites were able not only to 
support the adhesion and proliferation of mouse osteoblast-like 
cells but also to induce their osteogenic differentiation. This was 
evidenced by increased levels of expression and activity of the 
early osteogenic marker ALP in cells cultured on the composite 
material in comparison to those grown in chitosan scaffolds. 
 4.  Processing Methodology in Nanocomposites 
Engineering 
 Biopolymer/CaP nanocomposites are often obtained from 
CaP nanopowders/nanoparticles, which have been made 
through a large number of methods, namely wet chemical 
precipitation, sol-gel synthesis, hydrothermal synthesis, 
mechanochemical synthesis, microwave processing, and 
spray-drying methods. 
 Conventional techniques have commonly been used for 
scaffolding fabrication such as, foam replica method, solvent 
casting and particulate-leaching, freeze-drying, gas foaming 
and phase separation. These conventional methods are often 
inexpensive, simple to design, and fl exible to optimize or mod-
ulate physico-chemical properties. 
 Rapid prototyping and electrospinning for the production 
of 3D structures and nanofi bers, respectively, are sophisticated 
techniques, which have attracted a great deal of attention due 
to their ability to mimic new tissue structures and the possi-
bility of incorporating pharmaceutical agents. Molecular self-
assembly is another strategy available for the production of 
nanofi bers. 
 The aforementioned processing methodologies in nanocom-
posite engineering are overviewed as follows. 
 4.1.  Synthesis of CaP Nanopowders 
 CaP nanopowders/nanoparticles have been produced using 
a large number of methods, such as wet chemical precipi-
tation, [ 178–180 ] sol-gel synthesis, [ 178,181,182 ] hydrothermal syn-
thesis, [ 182,183 ] mechanochemical synthesis, [ 184 ] microwave 
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 Figure 12.  Microscopy images of SF nanofi bers (A) and SF nanofi bers modifi ed with HAp nanoparticles (B). Adapted with permission. [ 176 ] Copyright 
2013, Springer.
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irradiation-assisted processing, [ 185 ] and the spray-drying 
method. [ 186 ] Among them, the wet chemical process, also known 
as aqueous precipitation, is the most extensively investigated 
technique for CaP nanoparticle synthesis, followed by heat treat-
ment according to the desired CaPs structure. The advantage of 
this method relies on the homogeneity of the fi nal product, and 
the easiness of controlling parameters such as the precipitation 
temperature, pH, and the presence of additives during the syn-
thesis, which can affect the shape, stoichiometry, dimensions 
and specifi c surface area of the nanoparticles, and thereupon, 
their biodegradation properties. [ 187 ] The aqueous precipitation 
method often involves the reaction between calcium nitrate and 
diammonium hydrogen phosphate solutions as the chemical 
precursors for Ca and P, respectively. The addition of chemical 
agents such as citric acid, sodium citrate, amino acids and 
ethylene diamine tetra acetic acid (EDTA) have been used to 
stabilize the structure of the CaP nanoparticles. [ 180,188 ] CaP par-
ticles should be uniform in size and morphology, and spherical, 
for a satisfactory bioresorbability. Therefore, precipitation pro-
cedures, yielding a high density of crystallization nuclei, should 
be implemented in order to obtain nanosized particles. 
 4.2.  Foam Replica Method 
 Foam replica method is based in the impregnation of an 
aqueous suspension in porous synthetic polymeric (usually 
polyurethane) foams until the total fi lling of the pores. The 
impregnated foam is then passed through rollers or centri-
fuged to remove the excess suspension and allow the formation 
of a thin coating over the original structure and left to dry. [ 136 ] 
Then, the foams are carefully heated at temperatures between 
300–800 ºC, usually at heating rates lower than 1 ºC/min, for the 
slow decomposition and diffusion of the polymeric template, 
and thus a porous structure is obtained. Finally, the scaffolds 
are densifi ed by sintering at temperatures ranging from 1100 ºC 
to 1700 ºC, depending on the material. 
 This method allows the production of macroporous struc-
tures with a reticulated structure of highly interconnected pore 
sizes ranging from 200 µm to 3 mm at total open porosity levels 
between 40 and 95% ( Figure  13 ). [ 189 ] However, the mechanical 
strength of the produced structures can be degraded by the for-
mation of cracked struts during the decomposition of the foam 
(Figure  13 b). 
 4.3.  Solvent Casting and Particulate-Leaching 
 A combination of solvent casting and particulate-leaching meth-
odologies is widely used to successfully fabricate 3D porous 
scaffolds. [ 103,149 ] This is a process based on the dispersion of a 
salt (e.g., sodium chloride, ammonium bicarbonate, and glu-
cose) in a polymer dissolved in an organic solvent. The solvent is 
eliminated, resulting in the solidifi cation of the polymer. Then, 
the salt crystals are leached away using water to form the pores 
of the scaffolds ( Figure  14 ). The pore size can be controlled by 
the size of the salt crystals and the porosity by the salt/polymer 
ratio. Porosity values of up to 93% and average pore diameters 
of about 500 µm can be formed using this process. [ 190 ] However, 
certain critical variables such as pore shape and interconnec-
tivity of the pores are not controlled with this method. [ 191 ] 
 4.4.  Freeze-Drying 
 Freeze-drying, also known as lyophilization, is a dehydration 
technique, which allows freezing a material followed by drying 
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 Figure 13.  Microstructures of macroporous ceramics produced via the foam replica technique: a) alumina, b) silicon carbide, and c) HAp. Adapted 
with permission. [ 189 ] Copyright 2006, John Wiley and Sons.
 Figure 14.  Microstructure of a polyurethane scaffold prepared through 
solvent casting and particulate-leaching methods with salt particles of 
212–295 µm. Adapted with permission. [ 192 ] Copyright 2010, Elsevier.
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under vacuum. Firstly, a polymer is dissolved into a solvent 
with the addition of water, followed by freezing at different tem-
peratures and rates, forming ice crystals and forcing the mol-
ecules to aggregate in the interstitial spaces. [ 43 ] Then, the frozen 
material is dried at a low temperature under reduced pressure 
to remove the dispersed water and the solvent, thus leaving a 
porous polymeric structure. [ 38,103,138 ] One of the main advan-
tages of this process is the possibility to adjust the porosity of 
the foams to the desired needs by manipulating the freezing 
time and annealing stage. However, scaffolds produced using 
this method are not suitable for the use in conditions that 
imply mechanical stress, which is a consequence of the diffi -
culty in maintaining proper structural stability and mechanical 
properties after hydration. Moreover, the pore size is relatively 
small and the porosity is often irregular. [ 189,193 ]  
 Silk-based scaffolds using salt-leaching and freeze-drying 
suitable for meniscus and cartilage tissue engineering appli-
cations has been prepared ( Figure  15 ). [ 103,194 ] Morphological 
analysis showed that the structures possessed both macro and 
micro porosity with values up to 91% and the mean intercon-
nectivity up to 97%, depending on the polymer concentration 
in the structures. [ 194 ] 
 4.5.  Gas Foaming 
 The gas foaming technique utilizes high pressure CO 2 gas 
dispersed throughout a polymer mixed with a porogen (e.g., 
sodium chloride), until saturation. The solubility of CO 2 
is decreased rapidly until to atmospheric level resulting in 
nucleation and growth of gas bubbles. After completion of the 
foaming process, the porogen is removed and a highly inter-
connected pore structure is created. [ 195 ] The morphology of the 
scaffolds depends of the processing conditions, namely pres-
sure, temperature, and venting time ( Figure  16 ). [ 196 ] This tech-
nique does not require the use of organic solvents and high 
temperature as for the most fabrication techniques. 
 Porous polymeric foams prepared using the gas foaming 
technique has emerged in recent years with application as scaf-
folds for bone tissue engineering. [ 196–198 ] PCL/HAp nanocom-
posite scaffolds showed an overall porosity ranging from 75.7% 
to 83.4%, microporosity in the 20—100 µm range and macr-
oporosity in the range 200—600 µm. Results indicated that the 
micro-architecture of the pore structure of the scaffolds plays a 
crucial role in defi ning the cell seeding effi ciency, proliferation, 
and osteogenic differentiation. [ 198 ] 
 4.6.  Phase Separation 
 The phase separation technique is based on the separation 
into more than one phase in order to lower the system with 
free energy. Briefl y, a polymer solution separates into two 
phases, a polymer-rich phase and a polymer-lean phase, and 
when the solvent is removed, the polymer-rich phase solidi-
fi es. This technique has been used to fabricate porous mem-
branes for fi ltration and separation but has the disadvantage of 
forming pores with diameters on the order of a few to tens of 
Adv. Mater. 2015, 
DOI: 10.1002/adma.201403354
www.advmat.de
www.MaterialsViews.com
 Figure 15.  Microstructure of the cross-section morphology of SF scaffolds obtained by combining salt-leaching and freeze-drying methods. Adapted 
with permission. [ 194 ] Copyright 2012, Elsevier.
 Figure 16.  Microstructures of the cross sections along the foaming direction for foam specimens prepared at pressures of 60 and 200 bar. Scale bar 
100 µm. Adapted with permission. [ 196 ] Copyright 2011, John Wiley and Sons.
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micrometers that are not uniformly distributed. [ 199 ] However, 
controlled phase separation, as thermally induced phase sepa-
ration, has been used for scaffold fabrication. [ 200,201 ] This pro-
cess is based on the decrease in solubility associated with a 
temperature increase. After demixing is induced, the solvent 
can be removed by using extraction, evaporation, and freeze-
drying methods. Highly porous scaffolds made of PLLA by 
thermally induced phase separation starting from 1,4-dioxane/
PLLA solutions has been prepared for applications in vascular 
nets and angiogenesis ( Figure  17 ). [ 201 ] Microscopy images 
displayed pores organized into domains with different ori-
entations, showing dendrite-like and spherical structures. 
Overall and interconnected porosity values were in the range 
of 77–93% and 68–91%, respectively, depending on the phase 
separation temperature. 
 4.7.  Rapid Prototyping 
 Rapid prototyping (RP), also known as solid freeform fabrica-
tion or additive manufacturing, is an advanced technique that 
uses computer generated data, such as Computer Aided Design 
(CAD), Computed Tomography (CT) and Magnetic Resonance 
Imaging (MRI) data, to design complex-shaped objects. [ 141,202 ] 
The fabrication process involves an 3D design of the scaffold, 
which is directly produced layer-by-layer. As a result, this tech-
nique allows a precise control of the pore size, geometry, and 
interconnectivity, which enables tuning cells infi ltration and 
behavior into the scaffold. 
 Robocasting is a specifi c type of RP that allows the fabrica-
tion of a 3D structure by using a robotic arm to force the extru-
sion of a colloidal suspension through a microsized nozzle 
( Figure  18 a). [ 203 ] The ceramic ink placed in the injection syringe 
is then forced through the nozzle into an oil bath, resulting in 
porous scaffolds with a controlled architecture, enhanced com-
pressive strength and toughness as has been demonstrated 
with a porous β-TCP scaffold (Figure  18 b–d). [ 204 ] 
 4.8.  Electrospinning 
 Electrospinning has received considerable interest for the use 
in tissue engineering aimed at producing polymeric nanofi bers 
non-woven membranes scaffolds to the order of nanometers 
with large surface areas and superior mechanical properties. [ 205 ] 
This process is controlled by a high electric fi eld applied 
between two electrodes, being one placed in the polymer solu-
tion and the other is placed in the collector. During the elec-
trospinning process, a polymer solution is held at a needle tip 
by surface tension. This electrostatic force opposes the surface 
tension, causing the initiation of a jet, producing the fi bers. As 
the jet travels, the solvent evaporates and the nanofi bers are 
deposited in the collector ( Figure  19 A). [ 206 ] The characteristics 
of the nanofi bers depend on various properties of the solution 
and on the processing parameters. This process enables the 
production of scaffolds with interconnected pore structure and 
sub-micrometer diameter fi bers in a simpler and more cost-
effective way than other techniques like phase separation. 
 Composite branched-star PCL (*PCL) fi ber meshes loaded 
with HAp nanoparticles and clodronate produced by elec-
trospinning have been developed for bone repair and tissue 
engineering. [ 207 ] Results showed that the fi brous structure is 
composed of randomly oriented ultra-fi ne fi bers and that the 
inclusion of the active agents into polymer fi bers infl uenced the 
mesh morphology (Figure  19 B). 
 4.9.  Molecular Self-Assembly 
 Molecular self-assembly is a useful approach for producing 
supramolecular architectures that relies in the potential of 
molecules to spontaneously re-arrange themselves into well 
organized and stable structures under thermodynamic equilib-
rium conditions. Such molecular interactions are of non-cova-
lent nature and can occur through hydrogen and ionic bonds, 
hydrophobic and van der Waals forces, metal coordination, and 
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 Figure 17.  Microstructures of the scaffolds obtained by thermally induced phase separation performed with 6.4 wt% PLLA in 1,4-dioxane solutions: 
a–c) +4 ºC and d–f) –20 ºC. Adapted with permission. [ 201 ] Copyright 2010, Wiley.
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 Figure 18.  Schematic of robocasting fabrication process (a) and obtained microstructures of β-TCP scaffolds: b) general view, c) XY plane view and 
d) β-TCP rods. Adapted with permission. [ 204 ] Copyright 2006, Elsevier.
 Figure 19.  A) Schematic of electrospinning process. B) Microscopy images of electrospun scaffolds of the composites: a) PCL/nHAp, b) PCL/clodronate, 
and c) PCL/nHAp/clodronate. Adapted with permission. [ 206 ] Copyright 2011, MDPI. Adapted with permission. [ 207 ] Copyright 2010, John Wiley and Sons.
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electromagnetic interactions. [ 208 ] Self-assembly can occur spon-
taneously in nature, as the self-assembly of the lipid bilayer 
membrane in cells. It usually results in an increase in internal 
organization of the system, thus being referred as a “bottom-
up” manufacturing technique. Molecular self-assembly is a 
strategy for developing nanofi brous materials with the poten-
tial for tissue engineering ( Figure  20 ). [ 209,210 ] On a molecular 
scale, the accurate and controlled application of intermolecular 
forces can lead to new and previously unachievable nanostruc-
tures. Thus, the mechanical properties and the release profi les 
of the assembled materials can be tailored specifi cally for their 
intended use by appropriate design. [ 211 ] 
 5.  Natural Polymer/Calcium Phosphate 
Nanocomposites – Cell Interactions 
 Implants to be used for tissue engineering and regenerative 
medicine have been designed and characterized based on prin-
ciples used in some forms of in vitro biomineralization, such as 
immersion in a simulated body fl uid (SBF) or using cells (e.g. 
osteoblasts or stem cells) in static cultures or in bioreactor sys-
tems under dynamic conditions. 
 The use of regulatory signals, including biochemical and/
or biophysical stimuli in order to direct gene expression and 
cellular responses for inducing new tissue formation has also 
been exploited. In addition, in vivo performance using animal 
models have been used to evaluate the functionality and bio-
compatibility of the biomaterials. 
 5.1.  In Vitro Biomineralization Approaches 
 For over two decades, in vitro mineralization assays have been 
used as a biomimetic route to evaluate the potential bioactivity 
of the biomaterials in vivo. The common in vitro studies are 
performed by immersing the materials in SBF, as proposed by 
Kokubo, which serves as a source of Ca 2+ and PO 4 3− , or by static 
cultures cell seeding. [ 212 ] However, these in vitro culture tech-
niques have nutrient and mass transfer limitations that must 
be overcome to increase the feasibility of cell-based tissue engi-
neering strategies. 
 A different in vitro biomimetic approach including dynamic 
studies using bioreactor systems has been used to overcome the 
aforementioned limitations by continuously mixing media and 
by convectively transporting nutrients to cells, with appropriate 
mechanical stresses. [ 213 ] A bioreactor is a culture system 
designed to support or expand a population of cells through 
dynamic culture and a controlled environment. Besides, when 
considering 3D porous architectures, dynamic mineralization 
environments can also be suitable to promote a homogeneous 
formation of an apatite layer inside the structure.  Figure  21 
displays the cell distribution in the scaffolds after cell seeding 
in static and non-static conditions. Static culture seeding pro-
motes cell attachment and proliferation on the outer edge of 
the scaffolds, while non-static culture strategies encourage 
homogeneous cell seeding and proliferation of the scaffolds, as 
it enhances nutrient diffusion. 
 A wide array of bioreactor systems for bone tissue engi-
neering has been developed, as spinner fl asks, [ 215 ] rotating 
wall vessels, [ 216 ] and perfusion systems. [ 217 ] Spinner fl ask and 
rotating wall systems create a homogenous media on the exte-
rior of the scaffolds, while on perfusion systems, the media 
is perfused through the pores of the scaffolds, which enables 
local supply of nutrients providing a better control of the cell 
microenvironment. [ 218 ] 
 Some authors have studied the mineralization of apa-
tite layers under dynamic conditions using bioreactor sys-
tems. [ 213,219 ] Oliveira et al. [ 220 ] showed that bone-like apatite 
layers have been formed on the surface and inside of starch/
PCL scaffolds. Also, this process was accelerated under fl ow 
perfusion conditions, when compared with static and agitated 
conditions. 
 Perfusion bioreactor systems have been also reported to 
improve human mesenchymal stem cells (hMSCs) prolif-
eration and osteogenesis for tissue engineering. [ 221,222 ] For 
example, hMSCs cultured on nanofi brous electrospun PLGA/
PCL scaffolds to be implanted into rat femoral condyle defects, 
showed a superior bone regeneration in groups where implants 
were cultured in a with bioreactor as compared to that scaf-
folds cultured in static conditions. [ 221 ] Also, Canadas et al. [ 223 ] 
developed low acyl GG (LAGG) – LAGG/HA bilayered struc-
tures integrating cartilage- and bone-like layers, respectively, 
to allow the co-culture of rabbit adipose stem cells (rASCs)-
derived osteoblast and chondrocytes. The use of a successfully 
fabricated rotational dual chamber bioreactor enabled a higher 
diffusion of medium into the structure, while allowing the use 
of two different culture mediums for each layer. This device 
also ensured a homogeneous cell distribution throughout the 
scaffold, as well as the introduction of mechanical stimuli such 
as 180° stirring and compression of the top layer. Another 
study investigated the attachment of cardiac stem cells (CSCs) 
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 Figure 20.  Schematic of self-assembly technique, illustrating a microstructure of nanofi bers formed from peptide amphiphile. Adapted with permis-
sion. [ 210 ] Copyright 2011, Elsevier.
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to composites of collagen/poly(glycolic acid) nanofi bers using 
culture in a bioreactor perfusion system. [ 224 ] It was shown that 
the attachment and proliferation of CSCs in the 3D culture was 
enhanced by incubation in a bioreactor perfusion system com-
pared with static culture systems. 
 5.2.  Encapsulation and Release of Bioactive Molecules and Cells 
 5.2.1.  Bioactive Molecules 
 One of the signifi cant challenges in TERM is to fabricate scaf-
folds associated with bioactive signaling molecules that provide 
important cues and signals that can promote cell adhesion, pro-
liferation, differentiation, and metabolic activity for the in vivo 
regeneration process. These molecules are grouped in mitogens 
(that stimulate cell division), growth factors (with proliferation-
inducing effects), and morphogens (that control generation of 
tissue form). The most common bioactive molecules applied in 
TERM are provided in  Table  3 . [ 225,226 ] 
 Recombinant BMP growth factors are the most widely used 
for bone growth and regeneration owing their osteoinduction 
ability. [ 225,226,234 ] In vitro studies have shown that CaP composite 
scaffolds loaded with BMP-2 improved cell adhesion and prolif-
eration, and ALP activity. [ 226,235 ] Also, remarkable bone regen-
eration was observed after 8 weeks of scaffold implantation in 
rat skull defects. [ 235 ] In the same manner, Notodihardjo et al. [ 236 ] 
studied the effect of bone formation using rat calvarial bone 
by applying BMP-2 with or without HAp to the defects. Osteo-
chondrogenesis was highest for the mixed BMP-2/HAp group, 
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 Figure 21.  Static and dynamic cell attachment and proliferation onto the scaffolds. Reprinted with permission. [ 214 ] 
 Table 3.  Bioactive molecules for tissue engineering and regenerative medicine applications. 
Bioactive molecules Tissues Function References
PDFG (platelet-derived growth factor) Bone, cartilage, skin, muscle, blood vessel Mitogen for mesenchymal cells. Regulation of growth and 
division of cells
 [227] 
FGF (fi broblast growth factor) Bone, skin, nerve, blood vessel Migration, proliferation and survival of endothelial cells  [228,229] 
IGF (insulin-like growth factor) Bone, cartilage, liver, lung, kidney, skin, 
nerve
Cell proliferation, inhibition of cell apoptosis, and bone matrix 
formation
 [230] 
TGF (transforming growth factor) Bone, cartilage Wound healing and increase cell proliferation and 
differentiation
 [228,231] 
BMPs (bone morphogenetic protein) Bone, cartilage Osteoblast cells differentiation and migration  [226] 
EGF (epidermal growth factor) Skin, nerve Cell growth, proliferation and differentiation  [232] 
VEGF (vascular endothelial growth factor) Blood vessel Migration, proliferation and survival of endothelial cells.  [233] 
19wileyonlinelibrary.com© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
R
EV
IEW
followed by the BMP-2 and HAp groups within 4 weeks of 
implantation. Nevertheless, other biomolecules have been encap-
sulated in CaP-based nanocomposites with specifi c functions 
that can be used as part of tissue engineering therapies. [ 151,237,238 ] 
Farokhi et al. [ 151 ] developed a bio-hybrid SF/CaP/PLGA nanocom-
posite scaffold to be used as VEGF delivery system. It was shown 
that the release profi le of VEGF during 28 days has established 
the effi cacy of the scaffold as a sustained delivery system. In 
fact, the bioactivity of the released VEGF was maintained about 
83%. Besides, the scaffolds exhibited good biocompatibility, 
osteoblast cell adhesion, proliferation and alkaline phosphatase 
activity. The histology analysis has shown new bone formation 
after 10 weeks of implantation in a rabbit animal model. Keeney 
et al. [ 237 ] evaluated the capability of a collagen/CaP scaffold to 
deliver naked plasmid DNA and mediate transfection in vivo, as 
well as, a plasmid encoding pVEGF 165 to promote angiogenesis, 
and bone formation, in a mouse intra-femoral model. Results 
showed that the scaffolds with plasmids had higher bone volume 
in mouse defects in comparison to scaffolds alone. A different 
delivery system using anionic nanoparticles for small interfering 
RNA (siRNA) delivery for anticancer therapy was reported. [ 239 ] 
PEG – Carboxymethylchitosan/CaP hybrid anionic nanoparticles 
showed delivering siRNA into tumor cell capability and facili-
tated the escape of loaded siRNA from the endosome into the 
cytoplasm, leading to remarkable and specifi c gene knockdown 
effi cacy in cancer cells, without toxicity. 
 5.2.2.  Cells 
 Another strategy for TERM is the combination of scaffolds with 
cells, differentiated or undifferentiated, that can be implanted 
into the body to repair/regenerate a defect. [ 240 ] For that, it is cru-
cial to design a scaffold that will promote nutrients/metabolites 
diffusion and equal distribution of cells along to the center and 
inner surfaces of the scaffolds, since most of the cells have low 
capacity of invasion. Cellular attachment and proliferation is 
dependent on the scaffold architecture, such as material crys-
tallinity, porosity, pores size, and pore interconnectivity. [ 241,242 ] 
Figure  22 shows that cells seeding on microporous or micro-
fi brous scaffolds fl atten and spread as in two-dimensional sys-
tems, while nanoscale fi brous scaffolds increase cell binding 
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 Figure 22.  Cellular response to different scaffold architectures and pore sizes. Cells binding to scaffolds with microporous or microfi brous structures 
fl atten and spread, whereas nanofi brous scaffolds present more binding sites to cell membrane receptors improving cell attachment and cellular 
interactions. Adapted with permission. [ 242 ] Copyright 2005, Science.
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sites due to their higher surface area to volume ratio for the 
adsorption of proteins and binding of ligands. Cells cultured on 
nanostructured surfaces can form a more orderly layer than on 
fl at surfaces, and can make higher zone contacts improving cell 
attachment and cellular interactions. Scaffold porosity as well 
as the pores size can control the process of cells adhesion and 
migration to the surfaces of the scaffolds, and interconnecting 
pores allow cell growth inside the scaffold and nutrient fl ow. [ 243 ] 
Reviews for cell responses to surface and architecture of tissue 
engineering scaffolds have been reported elsewhere. [ 244 ] 
 The scaffold design is clearly an important contributing 
factor for the cell attachment and proliferation, but it is also 
necessary for the cells to be viable, produce an ECM and main-
tain normal tissue homeostasis. Different cell sources have 
been used to evaluate the cytotoxicity, compatibility, and cellular 
activities of the nanocomposites, such as osteoblasts, fi broblasts, 
hMSCs, human bone marrow stromal cells (HBMSCs), bone 
marrow-derived stem cells (BMSCs), and human endometrial 
stem cells (HESCs). [ 21,35,103,245–247 ] Fricain et al. [ 245 ] evaluated in 
vitro pullulan and dextran/nano-HAp composite scaffolds with 
HBMSCs seeding for bone regeneration. Results showed that 
the scaffolds induced the formation of multicellular aggregates 
and expression of early and late bone specifi c markers with 
HBMSC in medium deprived of osteoinductive factors. Yan 
et al. [ 103 ] used mouse lung fi broblasts (L929 cell line) seeded in 
SF/nano-CaP scaffolds to investigate the non-cytotoxicity of the 
scaffolds. Venugopal et al. [ 246 ] prepared a chitosan/HAp nanofi -
brous composite scaffold with enhanced human fetal osteoblasts 
(hFOBs) proliferation for bone tissue engineering. Liu et al. [ 248 ] 
demonstrated that a nanocomposite scaffold of HAp/chitosan 
can promote bone regeneration by supporting the adhesion, 
proliferation, and activating of integrin-BMP/Smad signaling 
pathway of BMSCs. Another report showed that nanocomposite 
scaffolds based on gelatin and CaP can support the attachment 
and proliferation of differentiated HESCs-derived osteoblast-
like cells as can be seen in  Figure  23 . [ 247 ] The presence of osteo-
pontin, osteonectin and ALP mRNA after differentiation in the 
HESCs was also confi rmed. 
 6.  In Vivo Studies of Natural Polymer/CaP 
Nanocomposites in Tissue Engineering and 
Regenerative Medicine 
 Up to now, several animal models, such as rats, mice, rabbits, 
sheeps, dogs and goats, have been used for TERM studies. 
 Table  4 summarizes the recently reported in vivo studies per-
formed on nanocomposites from biopolymers and CaPs. 
 Among different animal models used to evaluate the in vivo 
behavior of nanocomposite scaffolds, rat is the most used one, 
mainly because it is a relatively inexpensive model to estab-
lish. Also, they can reproduce fast, which enable the study of 
the function of particular genes during a reasonable period of 
time. [ 251 ]  Figure  24 shows a typical image section stained with 
the Masson’s trichrome of a SF/nano-CaP scaffold after implan-
tation in rat femur defect for 3 weeks. [ 38 ] It can be seen bone 
growth in the porous structure of the scaffold, with about 45% 
of new bone area, as well as no chronic infl ammation. 
 Concerning human clinical studies, FDA or European Medi-
cines Agency (EMEA) institutions must approve the release of 
biomaterial products before being employed in clinical applica-
tions. Consequently, only one pilot clinical trial study of natural 
polymers/CaP nanocomposites for the treatment of osteochon-
dral lesions has been reported so far. [ 252 ] A gradient tri-layer 
nanocomposite osteochondral scaffold based on collagen Type 
I/HAp, obtained by nucleating collagen fi brils with HAp nano-
particles has been implanted in the subchondral bone of 13 
 Figure 23.  Endometrial stem cells seeded on gelatin/CaP nanocomposite scaffold: a,b) SEM images showing adhered cells on the surface of the scaf-
fold; c) ALP activity production of cells (control: tissue culture polystyrene). Adapted with permission. [ 247 ] Copyright 2013, Elsevier.
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patients (15 defect sites) during 6 months. The scaffold cartilag-
inous layer consists of collagen, the intermediate layer consists 
of 60% collagen and 40% HAp, and the bone layer is composed 
of 30% collagen and 70% HAp. Histological analysis, although 
performed in only two cases, revealed the presence of perfectly 
formed subchondral bone and entirely scaffolds reabsorption. 
Nevertheless, it would be necessary to do follow-up studies of 
such procedure, especially regarding the histological quality of 
cartilage repair in the long term, in order to draw proper con-
clusions on its clinical effectiveness. Additional systematic anal-
yses are therefore needed so that the clinical and morphological 
outcomes are well evaluated when compared with other alterna-
tive treatments such as bone-marrow stimulation techniques, 
mosaicplasty and autologous chondrocyte transplantation. 
 7.  Concluding Remarks 
 Nanocomposite scaffolds combining biopolymers and nano-
sized CaPs have a great potential in TERM, due to their ability 
to mimic the structural and mechanical properties of native 
tissues. Natural polymers are appealing owing to their different 
degradation rates, whereas CaPs offer the required osteocon-
ductivity and biocompatibility features. 
 The great research efforts for designing an ideal nanocom-
posite material for the repair and regeneration of damaged/
diseased tissues have revealed the promise of nanocomposites 
comprising collagen, gelatin, silk fi broin, chitosan, alginate, 
hyaluronic acid, gellan gum, and derivatives as natural poly-
meric matrices, and HAp and β-TCP as bioactive fi llers. Bio-
mimetic strategies to produce nanocomposites for tissue engi-
neering scaffolding, with microporosity and tunable surface, 
focused on 3D porous scaffolds, hydrogels, and nanofi brous 
scaffolds. The latter has shown several advantages due to its 
fi brous nano- to micro-architecture, which can mimic the net-
work of collagen fi brils, homogeneous fi ber size, high porosi-
ties, and pore distribution. 
 CaP nanopowders/nanoparticles have been prepared through 
wet chemical precipitation (or aqueous precipitation), sol-gel 
synthesis, hydrothermal synthesis, mechanochemical syn-
thesis, microwave processing, and spray-drying methods. The 
most used technique is wet chemical owing the homogeneity of 
 Table 4.  Recent in vivo studies of natural polymer/CaP nanocomposite scaffolds. 
Nanocomposite scaffolds Animal model Results Reference
Chitosan/nanofi brous Hap SD rat cranium defect Bone regeneration in vivo after 10 and 20 weeks of implantation  [248] 
SF/nano CaP Wistar rat femur defect New bone ingrowth after 3 weeks of implantation, 
without infl ammatory response
 [38] 
PEG–PCL–PEG copolymer/collagen/ nano HAp Rat muscle Slight infl ammatory response at 7 days post-surgery due to the 
degradation of the implant, indicating a good biocompatibility 
and biodegradability.
 [162] 
Pullulan and dextran/ nano-HAp Rat femoral condyle Dense mineralized tissue increasing from 15 to 90 days of implantation  [245] 
PEG–PCL–PEG copolymer/collagen/ nano HAp New Zealand white rabbit 
cranial defect
New bone tissue formation initially from the edge of the defects 
and the surface of the native bone and grew towards the center
 [162] 
HAp/SF Rabbit New bone formation  [249] 
Calcium sulfate hemihydrate/ collagen/
nano-HAp
Rabbit femoral condyle New bone formation after 12 weeks of implantation.  [250] 
Pullulan and dextran/ nano-HAp Goat mandibular defect Dense mineralized tissue after 6 months of implantation. 
Dense lamellar collagen network
 [245] 
Pullulan and dextran/ nano-HAp Goat tibial ostetomy Dense mineralized tissue and regeneration of cortical bone 
after 6 months of implantation
 [245] 
 Figure 24.  Microscopy images of histological Masson’s trichrome stained section of SF/nano-CaP scaffold after implantation in rat femur defect for 
3 weeks. S: scaffold residuals; B: formed new bone; M: bone marrow; R: rapid forming new bone. Scale bars: a) 200 µm and b) 100 µm. Adapted with 
permission. [ 38 ] Copyright 2013, SAGE.
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the fi nal product and the easiness of para meters control during 
the synthesis. Conventional technologies used to fabricate the 
nanocomposite scaffolds include foam replica, solvent casting 
and particulate-leaching, freeze-drying, gas foaming and phase 
separation. Rapid prototyping and electrospinning are more 
sophisticated techniques for the production of 3D structures 
and fi bers, respectively, with the ability to mimic new tissue 
structures and the possibility of incorporating pharmaceutical 
agents. Additionally, molecular self-assembly is used to produce 
nanofi brous by creating supramolecular architectures. 
 Finally, nanocomposites from natural polymers and CaPs 
hold nano-featured structures, such as high surface area and 
enhanced porosity that are a must for the appropriate cellular 
adhesion, proliferation, and differentiation. Furthermore, they 
can be functionalized with bioactive molecules and stem cells 
in order to enhance tissue healing/regeneration. In vitro cell 
culturing in 3D using perfusion bioreactor systems may be also 
applied for producing mature tissues. Such dynamic systems 
can provide an optimal environment for convectively trans-
porting nutrients to cells and remove metabolites, with appro-
priate mechanical stresses, to guide cell growth and prolifera-
tion, and extracellular matrix production. 
 Succinctly, it can be concluded that the perfect natural nano-
composite scaffold, mimicking the hierarchical structure and 
morphology of bone while presenting a temporary function, has 
not yet been developed. Still, silk fi broin and collagen biopolymers 
combined with CaPs showed great promise in pre-clinical studies. 
 These scaffolds are still in stages of research and develop-
ment, lacking application in clinical surveys. Future develop-
ments of this kind of nanocomposites for tissue repair and 
regeneration, towards clinical applications, should be devoted 
on the clear understanding of the nanocomposite-tissue inter-
actions, on the optimization of their composition and hierar-
chical structure for long-term service, and the related mechan-
ical strength, especially the fatigue limit under periodic external 
stress. Besides, the use of these nanocomposites with thera-
peutic effect and drug delivery, combined with differentiated or 
undifferentiated autologous cells, should be deeply investigated. 
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